KYMR — Kymera Therapeutics, Inc.

KYMRKymera Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · kymeratx.com

79.94USD+1.33%Mkt Cap: 6.61B USDP/E: —Last update: 2026-05-26

Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natu…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap6.61B USD

Enterprise Value6.06B USD

Revenue (TTM)51.48M USD

Gross Profit-283.00M USD

Net Income (TTM)-311.35M USD

Revenue/Share0.5790 USD

Last Price79.94 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees253

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-18.44

PEG—

EV/EBITDA-17.39

EV/Revenue117.73

P/S128.81

P/B4.15

EPS (TTM)-3.58

EPS (Forward)-4.37

52W Range

28.0669% of range103.00

52W High103.00 USD

52W Low28.06 USD

Profitability

Gross Margin0.00%

Oper. Margin-244.88%

EBITDA Margin0.00%

Profit Margin-794.04%

ROE-19.71%

ROA-17.86%

Growth

Revenue Growth55.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-232.89M USD

CapEx (TTM)1.45M USD

FCF Margin-270.54%

FCF Yield-2.11%

Net Debt-570.46M USD

Net Debt/EBITDA1.64

Balance Sheet

Debt/Equity0.05

Current Ratio10.81

Quick Ratio10.39

Book Value/Sh19.42 USD

Cash/Share7.913 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.3 (Strong Buy)

Target (Mean)118.27 USD

Target Range91.00 USD – 140.00 USD

# Analysts22

Ownership

Shares Out.82.26M

Float55.05M

Insiders2.09%

Institutions117.73%

Short Interest

Short Ratio17.6d

Short % Float15.20%

Short % Out.11.78%

Shares Short9.69M

Short (prev mo.)10.40M

Technical

SMA 5083.18 (-3.9%)

SMA 20069.87 (+14.4%)

Beta2.06

S&P 52W Chg28.31%

Avg Vol (30d)500.00K

Avg Vol (10d)471.59K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—